The current and founding Director of the DNA Sequencing Core, Bob Lyons, Ph.D., will be retiring in September. To that end, the Medical School Office of Research is accepting nominations for a Faculty Director for the Biomedical Research Core Facilities (BRCF) DNA Sequencing Core.

Dr. Lyons’ position will be filled by two roles:

  • Managing Director (100% Staff Scientist position) to manage the day-to-day operations of the Core.
  • A Faculty Director (20% effort) who will partner and provide the managing director overall guidance to set the vision and strategic direction of the Core. Please note this is a renewable, two-year appointment.

The role of the Faculty Director is as follows:

DNA Sequencing capabilities and services are becoming increasingly critical to many biomedical research experiments and projects. The role of the DNA Sequencing Core is essential to many other core services (e.g. Epigenomics, Bioinformatics), and these connections are expected to increase in the near future. To that end, the Faculty Director of the DNA Sequencing Core is expected to lead a cutting-edge Core in a continuously evolving and growing field of science and collaboration.

The role of the Faculty Director includes, but is not limited to:

1)         Provides leadership and directional guidance/supervision to the Managing Director of the DNA Sequencing Core (to be hired).

2)         Provides guidance/direction in preparation of strategic plans for assessing and implementing new technologies and acquiring new instrumentation.

3)         Provides leadership over the continued implementation and development of new platforms/services and evaluates and reviews existing platforms.

4)         Guides the growth of relationships and interactions with Biomedical Research Core Facilities (BRCF) partner Cores.

5)         Seeks out effective partnerships with faculty and personnel in research laboratories across as well as outside U-M that will grow DNA Sequencing Core   business and exposure.

6)         Consults with investigators on issues related to experimental design and application of techniques as needed.

7)         Reviews and updates scientific and business plans for the Core’s continued growth and sustainability.

8)         Works in close collaboration with the Managing Director and BRCF administration to provide sound fiscal oversight and stewardship.

The Faculty Director for the DNA Sequencing Core will work closely with the BRCF Administration in evaluating the performance of the Managing Director. The Faculty Director will also be the primary advocate for the DNA Sequencing Core to Michigan Medicine and University leadership.

The Faculty Director and Managing Director will jointly convene and leverage a core-specific faculty advisory committee that represents the diverse interests of our research enterprise to identify and prioritize the needs of the research community. As a key leadership position within the Medical School Office of Research, the Faculty Director will also represent the DNA Sequencing Core at Faculty Research Leadership meetings.

The Faculty Director must be institutionally minded, be an active user of the DNA Sequencing Core with the capability to understand investigators’ broad sequencing needs, be able to see challenges as opportunities for improvement, and understand a service-oriented facility. 

To Apply:

Applicants must hold a U-M faculty appointment, preferably within the Medical School, at the Associate Professor rank or above, be an active scientist, and demonstrate strong leadership skills. Knowledge of the Medical School and University research policies and procedures is desirable. Nominations of potential candidates for the Faculty Director role can be sent to brcf-umms@umich.edu; self-nominations are welcome and encouraged.

Applicants must submit a cover letter expressing their interest and qualifications addressed to the attention of Steven L. Kunkel, Ph.D., Senior Associate Dean for Research as well as a current C.V. Please submit a single PDF electronically to brcf-umms@umich.edu by 5 PM, Friday August 17, 2018.